US Broker Ratings

Belite Bio, Inc (BLTE) Stock Analysis: Uncovering a 41.69% Potential Upside in the Biotech Arena

Belite Bio, Inc (NASDAQ: BLTE) is capturing attention in the biotechnology sector, driven by its innovative approach to addressing significant unmet medical needs. With a market capitalization of $1.95 billion,..

ImmunityBio, Inc. (IBRX) Stock Analysis: Unveiling a 264% Potential Upside for Biotech Investors

ImmunityBio, Inc. (IBRX) stands at the forefront of cutting-edge biotechnology innovation, as it continues to make significant strides in developing therapies that enhance the immune system’s natural ability to fight..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare Challenges with a 3.77% Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a significant player in the healthcare sector, specifically within the Health Information Services industry. Headquartered in Charlotte, North Carolina, Premier’s dual-segment business model is..

Disc Medicine, Inc. (IRON) Stock Analysis: Exploring an 88.91% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON) is creating a buzz in the biotechnology sector with its promising pipeline and significant upside potential for investors. With a current market capitalization of $1.8..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 61.34% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) stands as a noteworthy player in the healthcare sector, specializing in medical devices and diagnostic testing solutions. With a market capitalization of $1.98 billion, the company..

Galapagos NV (GLPG) Stock Analysis: Navigating a Path with Limited Upside

For investors keen on exploring opportunities in the biotechnology sector, Galapagos NV (GLPG), headquartered in Mechelen, Belgium, presents a unique case. Specializing in developing innovative medicines targeting oncology and immunology,..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Is a 120% Upside Within Reach for This Biotech Pioneer?

Apogee Therapeutics, Inc. (APGE), a biotechnology firm rooted in the healthcare sector, is making waves with its promising portfolio of innovative treatments for various inflammatory and immunological conditions. With a..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential

Envista Holdings Corporation (NYSE: NVST) remains a company to watch in the healthcare sector, specifically within the realm of medical instruments and supplies. With a market capitalization of $3.22 billion,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 25.69% Upside Potential Amidst Biotech Growth

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a cutting-edge biopharmaceutical company focused on developing innovative peptide therapeutics, has been gaining significant attention from investors. With a market capitalization of $3.39 billion, the..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Strong Buy Ratings and 66% Potential Upside in Medical Devices Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a prominent player in the healthcare sector specializing in medical devices, has emerged as a company of interest for investors seeking growth opportunities in the..

Sotera Health Company (SHC) Stock Analysis: A 31% Potential Upside Beckons Investors

Sotera Health Company (NASDAQ: SHC), a prominent player in the healthcare sector’s diagnostics and research industry, presents a compelling case for investors seeking growth potential amidst market volatility. With a..

HUTCHMED (HCM) Stock Analysis: Unpacking a 52.88% Potential Upside for Savvy Investors

In the ever-evolving landscape of the healthcare sector, HUTCHMED (China) Limited (HCM) stands out with its significant potential upside of 52.88%, as suggested by analyst ratings. This Hong Kong-based specialty..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings and a 25% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a compelling investment opportunity in the biotechnology sector, with a market capitalization of $2.22 billion. The company, based in Jupiter, Florida, is a..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A Biotech Pioneer with 18.89% Potential Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a force to be reckoned with in the biotechnology sector, commanding a market capitalization of $4.11 billion. As a company dedicated to developing treatments..

NewAmsterdam Pharma (NAMS) Stock Analysis: A 117.83% Upside in the Healthcare Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a notable player in the biotechnology industry, has been capturing investor attention with its promising pipeline and impressive potential upside. With a market capitalization..

Vericel Corporation (VCEL) Stock Analysis: Why a 42.76% Potential Upside Could Entice Investors

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention due to its promising growth potential. With a market capitalization of $2.09 billion, Vericel is..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Investors with an eye on the healthcare sector might find Surgery Partners, Inc. (NASDAQ: SGRY) an intriguing opportunity, especially considering its potential upside of 35.36% based on current analyst targets...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A 56.70% Potential Upside Amidst Promising Neurological Therapeutics

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the healthcare sector with a focus on biotechnology, continues to capture investor interest with its innovative approach to treating rare..

Merus N.V. (MRUS) Stock Analysis: A 69% Upside Potential in the Biotech Sector

Merus N.V. (NASDAQ: MRUS), a clinical-stage biotechnology firm based in the Netherlands, is garnering significant attention in the investor community. With a promising pipeline of innovative bispecific antibody therapeutics targeting..

Acadia Healthcare Company, Inc. (ACHC): Analyst Consensus Suggests Over 100% Upside Potential

Investors looking for opportunities in the healthcare sector should take a closer look at Acadia Healthcare Company, Inc. (NASDAQ: ACHC). With a market cap of $1.95 billion, this company specializes..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds